AR has long been used in CRC treatment by TCM practitioners in ancient China as well as in modern clinical practice without reported toxicity, and our experimental findings indicate that AR exerted anti-CRC effects in vitro, suggesting that the multi-component and multi-target AR may have greater clinical significance compared to specific STAT3 inhibitors. The gene discussed is AR; the disease is colorectal carcinoma.